electroCore,

electroCore, Current Assets

The Current Assets of electroCore, (ECOR) as of Oct 17, 2026 is 10.58 M USD. In the previous year, Current Assets was 16.30 M USD — a change of -35.07% (lower).

Current Assets

10.58 MUSD

YoY

-35.07%

Last updated:

Current Assets of electroCore, is 2025 10.58 M USD. Current Assets of electroCore, was 2024 16.30 M USD. It decreases by -35.07% lower compared to the previous year.

The electroCore, Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
74.62 M USD
Jan 1, 2019
26.54 M USD
Jan 1, 2020
25.06 M USD
Jan 1, 2021
37.54 M USD
Jan 1, 2022
21.17 M USD
Jan 1, 2023
14.29 M USD
Jan 1, 2024
16.30 M USD
Jan 1, 2025
10.58 M USD
The electroCore, Current Assets history
YEARCurrent AssetsYoY
10.58 MUSD-35.07%
16.30 MUSD+14.03%
14.29 MUSD-32.49%
21.17 MUSD-43.61%
37.54 MUSD+49.79%
25.06 MUSD-5.55%
26.54 MUSD-64.44%
74.62 MUSD+91.18%
39.03 MUSD+7,686.90%
501,229.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about electroCore, stock

Current Assets of electroCore, is 10.58 M USD in 2025.

Current Assets of electroCore, changed from 16.30 M USD to 10.58 M USD, representing a -35.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets electroCore, since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's electroCore, historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — electroCore,

All Key Metrics — electroCore,